Lipoic acid stimulates cAMP production in T lymphocytes and NK cells.

[1]  T. Yamamura,et al.  Differential Expression of CD11c by Peripheral Blood NK Cells Reflects Temporal Activity of Multiple Sclerosis1 , 2006, The Journal of Immunology.

[2]  R. Musters,et al.  Lipoic Acid Affects Cellular Migration into the Central Nervous System and Stabilizes Blood-Brain Barrier Integrity1 , 2006, The Journal of Immunology.

[3]  D. Bourdette,et al.  Lipoic acid inhibits expression of ICAM-1 and VCAM-1 by CNS endothelial cells and T cell migration into the spinal cord in experimental autoimmune encephalomyelitis , 2006, Journal of Neuroimmunology.

[4]  T. Waldmann,et al.  Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[5]  W. Woodward,et al.  Lipoic acid in multiple sclerosis: a pilot study , 2005, Multiple sclerosis.

[6]  D. Bourdette,et al.  α lipoic acid inhibits human T‐cell migration: Implications for multiple sclerosis , 2004, Journal of neuroscience research.

[7]  A. Howe.  Regulation of actin-based cell migration by cAMP/PKA. , 2004, Biochimica et biophysica acta.

[8]  L. Roccatagliata,et al.  α-Lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis , 2004, Journal of Neuroimmunology.

[9]  J. Regan.  EP2 and EP4 prostanoid receptor signaling. , 2003, Life sciences.

[10]  D. Bourdette,et al.  Alpha lipoic acid inhibits T cell migration into the spinal cord and suppresses and treats experimental autoimmune encephalomyelitis , 2002, Journal of Neuroimmunology.

[11]  J. Regan,et al.  Phosphorylation of Glycogen Synthase Kinase-3 and Stimulation of T-cell Factor Signaling following Activation of EP2 and EP4 Prostanoid Receptors by Prostaglandin E2 * , 2002, The Journal of Biological Chemistry.

[12]  E. Kuklina,et al.  Role of cAMP-dependent signal transduction in the control of T lymphocyte activation. , 2000, Biochemistry. Biokhimiia.

[13]  D. Carr,et al.  Regulation of IL-15-Stimulated TNF-α Production by Rolipram , 1999, The Journal of Immunology.

[14]  S. Narumiya,et al.  Prostanoid receptors: structures, properties, and functions. , 1999, Physiological reviews.

[15]  J. Regan,et al.  6-Isopropoxy-9-oxoxanthene-2-carboxylic acid (AH 6809), a human EP2 receptor antagonist. , 1995, Biochemical pharmacology.

[16]  R. Steinman,et al.  Proliferating dendritic cell progenitors in human blood , 1994, The Journal of experimental medicine.

[17]  T. Springer,et al.  Leukocyte integrin P150,95 (CD11c/CD18) functions as an adhesion molecule binding to a counter-receptor on stimulated endothelium. , 1991, Journal of immunology.

[18]  P. Lumley,et al.  AH6809, a prostaglandin DP‐receptor blocking drug on human platelets , 1988, British journal of pharmacology.

[19]  L. Roccatagliata,et al.  Alpha-lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis. , 2004, Journal of neuroimmunology.

[20]  D. Carr,et al.  Regulation of IL-15-stimulated TNF-alpha production by rolipram. , 1999, Journal of immunology.